Sign In

David Rossow

Strategic Investor at the Gates Foundation

David Rossow is a seasoned professional with a rich background in investments and strategic partnerships.

As the Founding Partner and Head of International for the Gates Foundation's $2.5 billion Strategic Investment Fund, he focuses on biotech in Europe, Israel, and tech-enabled services/product delivery in South Asia and Sub-Saharan Africa.

He studied at St. Olaf College, shaping his academic foundation.

David has held roles as a Board Observer at various organizations such as Halodoc ID, bKash Limited, CureVac AG, LumiraDx, Kymab Ltd, Stellapps Technologies Private Limited, Immunocore, Visterra Inc., and Affinivax Inc.

Prior to his current role, he served as a Founding Partner of the Gates Foundation Strategic Investment Fund at the Bill & Melinda Gates Foundation, showcasing his aptitude for strategic investment decisions in the social sector.

His experience extends to being a Board Observer at Uversity, Inc. and a Private Equity Associate at ShoreView Industries, LLC.

David Rossow's early career involved working as an Investment Banking Analyst at Lazard, where he honed his financial acumen.

His diverse experiences in various sectors reflect his expertise in global investments, private equity, and strategic decision-making, especially within the healthcare and technology industries.

David Rossow
Add to my network

Location

Greater London, England, United Kingdom